1. India Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
Suraksha Diagnostic Limited

Suraksha Diagnostic Limited

SURAKSHA.NS
Suraksha Diagnostic LimitedIN flagNational Stock Exchange of India
284.20
INR
-7.05
- -
14.80BMarket Cap
Suraksha Diagnostic Limited
SURAKSHA.NS
(National Stock Exchange of India)

Recent

price

284.20

P/E

ratio

- -

div

yld

- -

ROIC.AI

2022
2023
2024
2025
2026
TTM
FRC
42.86
36.51
41.99
47.29
- -
59.61
Revenue per Share
4
1.25
4.54
5.97
- -
6.18
Basic EPS, GAAP
7.41
5.94
2.88
4
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
18.4
20.34
24.85
30.87
- -
2
Book Value per Share
27.35
29.26
33.88
39.06
- -
45.44
Tangible Book Value per Share
52
52
52
53
- -
52
Basic Weighted Avg Shares
2,232
1,901
2,187
2,521
3,104
3,104
Sales/Revenue/Turnover
16.42
8.3
18.73
19.09
17.53
17.53
Operating Margin (%)
284
317
326
353
414
414
Depreciation Expense
208
65
236
318
322
322
Net Income, GAAP
25.66
10.12
26.47
25.18
29.52
29.52
Effective Tax Rate (%)
9.33
3.43
10.8
12.62
10.37
10.37
Profit Margin (%)
247
297
330
44
29
29
Working Capital
831
804
755
741
1,143
1,143
LT Debt
1,458
1,555
1,791
2,102
2,435
2,435
Total Equity
- -
5.73
11.62
12.79
11.47
11.47
Return on Invested Capital (%)
- -
7.53
14.39
16.44
21.35
21.35
Return on Capital (%)
- -
6.46
20.08
21.65
36.79
36.79
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
156
- -
161
LT Borrowings
8
- -
2
LT Finance Leases
1,013
- -
1,141
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
52
- -
52
Market Capitalization
15,539
14,051
11,870

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
734
- -
626
Cash, Cash Equivalents & STI
446
- -
270
Accounts Receivable, Net
136
- -
228
Inventories
84
- -
81
Total Current Liabilities
418
- -
596
Payables & Accruals
- -
- -
- -
ST Debt
156
- -
161
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
15.81%
Free Cash Flow
- -
- -
-32.11%
Net Income, GAAP
- -
- -
1.14%
Sales/Revenue/Turnover
- -
- -
23.13%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
600
518
552
- -
2,187
2025
607
668
595
651
2,521
2026
726
787
777
814
3,104

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.62
0.89
- -
- -
4.54
2025
1.52
1.99
1.18
1.42
5.97
2026
1.8
1.73
1.44
1.21
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Precision System Science Co., Ltd. (PCNEF)
Spectral Medical Inc. (EDT.TO)
GRAIL, Inc. Common Stock (GRALV)
LumiraDx Limited (LMDX)
StageZero Life Sciences Ltd. (SZLSF)
Biocept, Inc. (BIOCQ)
Business
Suraksha Diagnostic Limited operates as an integrated diagnostic services provider offering comprehensive pathology, radiology, and medical consultation services across eastern India. The company delivers over 2,300 tests encompassing routine and specialized pathology including biochemistry, hematology, histopathology, molecular biology, cytogenetics, and next-generation sequencing; advanced radiology such as X-rays, ultrasonography, CT scans, MRI, and specialized imaging; cardiology tests like electrocardiograms, echocardiograms, stress tests, and Holter monitoring; gastroenterology procedures including endoscopies and colonoscopies; as well as neurology, dental, physiotherapy, immunology, rheumatology, eye care, fetal care, ENT, and specialty clinic consultations through its polyclinics with over 1,000 doctors. It maintains a hub-and-spoke model featuring a flagship 40,000 square foot central reference laboratory in New Town, Kolkata equipped with AI-enabled robotic tracks, liquid chromatography, and mass spectroscopy; eight satellite laboratories; 49 diagnostic centers comprising 13 hub centers, 11 medium centers, 23 small centers, and two public-private partnership centers; and 166 sample collection centers primarily in West Bengal, Bihar, Assam, Meghalaya, and Delhi NCR, supported by home collection, house calls, and digital report delivery. Founded in 1992 and headquartered in Kolkata, West Bengal, Suraksha Diagnostic employs approximately 1,175 staff and utilizes equipment from leading vendors including Siemens Healthineers, Wipro GE Healthcare, Roche Diagnostics, and Beckman Coulter. Recent developments include the April 2025 acquisition of a 63% stake in Fetomat Wellness Private Limited for maternal-fetal medicine and genomic integration; the launch of Suraksha Genomics in Q1 FY26 for advanced genetic and molecular testing; addition of 11 centers in H1 FY26 with plans for three more hub and six spoke centers; a December 2024 IPO raising Rs 846.25 crore for expansion; and subsidiaries such as Suraksha Radiology Private Limited and Asian Institute of Immunology and Rheumatology LLP.